DEA to Host Listening Sessions on Remote Prescribing

On August 4, 2023, the Drug Enforcement Administration (“DEA”) announced plans to host two public listening sessions, scheduled to take place on September 12 and 13, 2023 at DEA’s headquarters in Arlington, VA, to collect additional input regarding the practice of telemedicine and specifically the remote prescribing of controlled substances without conducting an in-person evaluation of patients before prescribing….
By: Epstein Becker & Green
Previous Story

SEC Adopts New Cybersecurity Reporting Rules, Setting Up Various Compliance Challenges

Next Story

Colorado DOI Fast-Tracks Big Data Governance Rulemaking